Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging
Tsuchimochi, S.; Nakajo, M.; Nakabeppu, Y.; Tani, A.
Clinical Nuclear Medicine 22(10): 687-690
1997
ISSN/ISBN: 0363-9762 PMID: 9343724 Document Number: 476430
Pulmonary metastases from malignant pheochromocytoma were seen with I-123 MIBG SPECT in a 16-year-old girl but were not visualized with I-123 MIBG planar imaging. She had a left adrenalectomy for a pheochromocytoma 7 years earlier. Two small pulmonary nodules were seen on chest X-ray and CT scans.
Document emailed within 1 workday
Related Documents
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28Samnick, S.; Kirsch, C.M. 1999: A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications Nuklearmedizin. Nuclear Medicine 38(7): 292-296
Gough, I.R.; Thompson, N.W.; Shapiro, B.; Sisson, J.C. 1985: Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas Surgery 98(1): 115-120
Rufini, V.; Troncone, L.; Valentini, A.L.; Danza, F.M. 1988: A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas La Radiologia Medica 76(5): 466-470
Kao, P.F.; Huang, M.J.; You, D.L.; Tzen, K.Y. 1992: Using 131I-MIBG and 99mTc-MDP bone scan for localization of rare extra-adrenal pheochromocytomas: report of 2 cases Journal of the Formosan Medical Association 91(Suppl 4): S283-S287
Hayashi, I.; Makuuchi, H.; Naruse, Y.; Kobayashi, T.; Yamamoto, T.; Hariya, A.; Maruno, H.; Murata, H. 1995: The clinical value of MIBG myocardial spect before and after CABG--comparison with Ti myocardial spect Nihon Kyobu Geka Gakkai 43(9): 1670-1674
Acar, P.; Merlet, P.; Iserin, L.; Bonnet, D.; Aggoun, Y.; Sidi, D.; Kachaner, J. 1996: Cardiac MIBG imaging: a new marker for myocardial function in children? Archives des Maladies du Coeur et des Vaisseaux 89(5): 599-604
Martins, E.; Faria, T.; Silva-Cardoso, J.; Oliveira, A.; Campelo, M.; Amorim, S.; Moura, B.; Rocha-Gonçalves, F.; Pereira, J.G.; Maciel, M.J.úl. 2009: I-123-MIBG cardiac uptake imaging, in familial dilated cardiomyopathy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(1): 29-36
Muiño Miguez, A.; Robles Pérez, R.; López Gómez, J.M.; Valderrábano Quintana, F. 1986: False-positive MIBG test in the localization of pheochromocytoma. a call to attention Medicina Clinica 86(10): 437
Houghton, A.; Clarke, S.; Jourdan, M. 1990: False-positive diagnosis of adrenal phaeochromocytoma on metaiodobenzylguanidine (MIBG) [correction of MIGB] scan British Journal of Clinical Practice 44(10): 411-412
Maurea, S.; Cuocolo, A.; Reynolds, J.C.; Neumann, R.D.; Salvatore, M. 1996: Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 40(4): 365-371
Troncone, L.; Rufini, V.; Campioni, P.; Valle, G.; Giordano, C.; Ala, G.; Deleide, G.; Orlando, P. 1985: Evaluation of a new adrenomedullary imaging agent: 131I-meta-iodobenzylguanidine (131I-MIBG). I: Experimental studies on animals Rays 10(2): 117-124
Aktolun, C.; Castellani, M.R. 2013: Theranostic role of MIBG in neuroblastoma Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 3-5
Flux, G.D.; Chittenden, S.J.; Saran, F.; Gaze, M.N. 2011: Clinical applications of dosimetry for mIBG therapy Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(2): 116-125
Lumbroso, J.; Schlumberger, M. 1990: Clinical applications of radio-labelled mIBG La Revue du Praticien 40(2): 140-142
Elgazzar, A.H.; Gelfand, M.J.; Washburn, L.C.; Clark, J.; Nagaraj, N.; Cummings, D.; Hughes, J.; Maxon, H.R. 1995: I-123 MIBG scintigraphy in adults. A report of clinical experience Clinical Nuclear Medicine 20(2): 147-152
Agostini, D.; Verberne, H.J.; Hamon, M.; Jacobson, A.F.; Manrique, A. 2008: Cardiac 123I-MIBG scintigraphy in heart failure Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 52(4): 369-377
O'Donoghue, J.A.; Wheldon, T.E.; Babich, J.W.; Moyes, J.S.; Barrett, A.; Meller, S.T. 1991: Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma Progress in Clinical and Biological Research 366: 455-461
Cornelissen, J.; Van Belzen, R.; Van Gennip, A.H.; Voûte, P.A.; Van Kuilenburg, A.B. 1997: Specification of the inhibitory action of MIBG on the respiratory chain by EPR scanning Anticancer Research 17(1a): 265-268
Hattner, R.S.; Pounds, T.R.; Matthay, K.K. 1994: Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans Clinical Nuclear Medicine 19(11): 985-988